Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.70 |
| ▸ | ANPEP | P15144 | 1/20 | 0.67 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.67 |
| ▸ | DNPEP | Q9ULA0 | 1/20 | 0.67 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.66 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.66 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.66 |
| ▸ | CPA3 | P15088 | 3/20 | 0.61 |
| ▸ | CPA1 | P15085 | 2/20 | 0.61 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.61 |
| ▸ | CPB1 | P15086 | 1/20 | 0.61 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.61 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.60 |
| ▸ | MME | P08473 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12494053 | 0.91 | CYP1A2 (0.63) | CYP1A2ANPEPRNPEPDNPEPSLC1A3 | |
| SCHEMBL9622038 | 0.90 | CYP1A2 (0.86) | CYP1A2SLC1A3SLC1A2SLC1A1CPA3 | |
| SCHEMBL7432418 | 0.90 | CYP1A2 (0.86) | CYP1A2SLC1A3SLC1A2SLC1A1CPA3 | |
| SCHEMBL7439697 | 0.90 | CYP1A2 (0.86) | CYP1A2SLC1A3SLC1A2SLC1A1CPA3 | |
| SCHEMBL8315228 | 0.87 | CYP1A2 (0.68) | CYP1A2ANPEPRNPEPDNPEPSLC1A3 | |
| SCHEMBL28126947 | 0.87 | CYP1A2 (0.57) | CYP1A2ANPEPRNPEPDNPEPCPA1 | |
| SCHEMBL5054321 | 0.85 | CYP1A2 (0.66) | CYP1A2ANPEPRNPEPDNPEPSLC1A3 | |
| SCHEMBL19483349 | 0.85 | ANPEP (0.55) | CYP1A2ANPEPRNPEPDNPEPSLC1A3 | |
| SCHEMBL9698417 | 0.84 | ANPEP (0.62) | CYP1A2ANPEPRNPEPDNPEPSLC1A3 | |
| SCHEMBL18327097 | 0.84 | CYP1A2 (0.63) | CYP1A2ANPEPRNPEPDNPEPSLC1A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 296 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4719194-A1 | METHODS FOR INCORPORATING THERAPEUTIC AGENTS INTO ANALYTE SENSORS | Abbott Diabetes Care, Inc. (US) | 2026-04-08 | — | — | EP | claimed |
| EP-4642438-A1 | DRUG DELIVERY COMPOSITIONS AND METHODS OF CONTROLLING DRUG DELIVERY RATES OF SUBCUTANEOUS SENSORS | Abbott Diabetes Care Inc. (US) | 2025-11-05 | — | — | EP | claimed |
| EP-3840637-B1 | MEDIATED DRUG RELEASE FOR REDUCING IN VIVO ANALYTE INDICATOR DEGRADATION | SENSEONICS INC (US) | 2025-08-06 | — | — | EP | claimed |
| US-20240423511-A1 | METHODS FOR INCORPORATING THERAPEUTIC AGENTS INTO ANALYTE SENSORS | ABBOTT DIABETES CARE INC. (US) | 2024-12-26 | — | — | US | claimed |
| WO-2024243577-A1 | METHODS FOR INCORPORATING THERAPEUTIC AGENTS INTO ANALYTE SENSORS | ABBOTT DIABETES CARE INC. (US) | 2024-11-28 | — | — | WO | claimed |
| WO-2024145693-A1 | DRUG DELIVERY COMPOSITIONS AND METHODS OF CONTROLLING DRUG DELIVERY RATES OF SUBCUTANEOUS SENSORS | ABBOTT DIABETES CARE INC. (US) | 2024-07-04 | — | — | WO | claimed |
| US-20240216589-A1 | DRUG DELIVERY COMPOSITIONS AND METHODS OF CONTROLLING DRUG DELIVERY RATES OF SUBCUTANEOUS SENSORS | ABBOTT DIABETIS CARE INC. (US) | 2024-07-04 | — | — | US | claimed |
| EP-4271273-A1 | AN ANALYTE SENSOR AND SHARP FOR DELIVERING A THERAPEUTIC AGENT IN CLOSE PROXIMITY TO AN ANALYTE SENSOR AND METHODS THEREFORE | Abbott Diabetes Care, Inc. (US) | 2023-11-08 | — | — | EP | claimed |
| CN-116997293-A | Analyte sensor and sharp element for delivering a therapeutic agent in close proximity to the analyte sensor and method therefor | 雅培糖尿病护理公司 | 2023-11-03 | — | — | CN | claimed |
| US-11672860-B2 | Drug eluting matrix on analyte indicator | SENSEONICS, INCORPORATED (US) | 2023-06-13 | — | — | US | claimed |
| US-9931068-B2 | Drug elution for in vivo protection of bio-sensing analytes | SENSEONICS, INCORPORATED (US) | 2018-04-03 | — | — | US | claimed |
| WO-2017077284-A1 | DRUG DELIVERY COMPOSITION CONTAINING SILYL POLYMERS | MEDHERANT LIMITED (GB) | 2017-05-11 | — | — | WO | claimed |
| EP-3035849-A1 | DRUG ELUTION FOR IN VIVO PROTECTION OF BIO-SENSING ANALYTES | Senseonics, Incorporated (US) | 2016-06-29 | — | — | EP | claimed |
| US-20150057509-A1 | DRUG ELUTION FOR IN VIVO PROTECTION OF BIO-SENSING ANALYTES | SENSEONICS, INCORPORATED (US) | 2015-02-26 | — | — | US | claimed |
| WO-2015027018-A1 | DRUG ELUTION FOR IN VIVO PROTECTION OF BIO-SENSING ANALYTES | SENSEONICS, INCORPORATED (US) | 2015-02-26 | — | — | WO | claimed |
| WO-2009137827-A2 | CONTROLLED RELEASE OF N-ACETYLCYSTEINE (NAC) FOR REDUCTION OF SYSTEMIC AND/OR VASCULAR INFLAMMATION | TIARA PHARMACEUTICALS, INC. (US) | 2009-11-12 | — | — | WO | claimed |
| US-5833715-A | Implantable stimulation lead having an advanceable therapeutic drug delivery system | PACESETTER, INC. (US) | 1998-11-10 | — | — | US | claimed |
| US-5531780-A | Implantable stimulation lead having an advanceable therapeutic drug delivery system | PACESETTER, INC. (US) | 1996-07-02 | — | — | US | claimed |
| EP-0428352-B1 | Anti-inflammatory compositions for external use | BETA PHARM CO (UY) | 1995-08-09 | — | — | EP | claimed |
| EP-0428352-A1 | Anti-inflammatory compositions for external use | Beta Pharmaceuticals Co. (UY) | 1991-05-22 | — | — | EP | claimed |